Property:Modification date

"Modification date" is a predefined property that corresponds to the date of the last modification of a subject and is provided by Semantic MediaWiki. This property is pre-deployed (also known as special property) and comes with additional administrative privileges but can be used just like any other user-defined property.

Usage1768

previous 202050100250500next 20

Filter<p>The <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Property_page/Filter">search filter</a> allows the inclusion of <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Help:Query_expressions">query expressions</a> such as <code>~</code> or <code>!</code>. The selected <a rel="nofollow" class="external text" href="https://www.semantic-mediawiki.org/wiki/Query_engine">query engine</a> might also support case insensitive matching or other short expressions like:</p><ul><li><code>in:</code> result should include the term, e.g. '<code>in:Foo</code>'</li></ul><ul><li><code>not:</code> result should to not include the term, e.g. '<code>not:Bar</code>'</li></ul>

Showing 20 pages using this property.

U

USA FDA Guidance for Industry - Computerized Systems Used in Clinical Investigations May-2007 IV +

11:50:07, 16 July 2026  +

USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 +

12:15:27, 16 July 2026  +

USA FDA Guidance for Industry - Computerized Systems Used in Clinical Trials 13-Apr-2015 III +

11:50:07, 16 July 2026  +

USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 +

12:15:27, 16 July 2026  +

USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15 +

11:50:10, 16 July 2026  +

USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 +

12:15:27, 16 July 2026  +

USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 GLOSSARY OF TERMS +

11:50:07, 16 July 2026  +

USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 II +

11:50:08, 16 July 2026  +

USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 III 2. +

11:50:07, 16 July 2026  +

USA FDA Guidance for Industry - Electronic Source Data in Clinical Investigations Sep-2013 III 4. +

11:50:08, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 +

12:15:28, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III - IV. +

11:50:10, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 III B. 3. +

11:50:10, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. +

11:50:10, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Adherence +

11:49:54, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Conduct +

11:49:55, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 IV A. Verification +

11:49:51, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI C. +

11:49:46, 16 July 2026  +

USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 VI D. +

11:50:10, 16 July 2026  +

USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 +

12:15:28, 16 July 2026  +